Heidelberg, Germany
PromoCell, a Germany-based biotechnology leader, has been driving scientific innovation since its founding in 1990. The company's mission is encapsulated by their slogan: "Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services."
With a portfolio featuring top-tier human primary, stem, and blood cells alongside optimized culture media, PromoCell provides essential tools for groundbreaking research. Their commitment to quality is reinforced by ISO and EXCiPACT™ GMP certifications, ensuring adherence to GMP standards for pharmaceutical excipients. Notably, their products are featured in approximately 600 peer-reviewed publications annually, highlighting their academic impact.
Operating in over 36 countries, PromoCell not only complies with European biomedical conventions for protecting human rights and donor privacy, but also holds a pivotal role in biotech and healthcare industries. Despite their established global footprint, recent investment rounds remain unreported, presenting a potential opportunity for investors to engage with this seasoned company.
